Skip to content

Adrenocorticotropic/Acth Analysis Product

by Nichols Institute

510(k) K926396

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK926396 Date27 Jul 1993ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
CKG
Device Class
Class II
Regulation
21 CFR Part 862.1025
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a radioimmunoassay (RIA) kit for the quantitative analysis of adrenocorticotropic hormone (ACTH) in clinical chemistry applications. It employs immunochemical techniques to measure ACTH levels in serum or plasma, aiding in the diagnosis and monitoring of conditions such as adrenal insufficiency, Cushing’s syndrome, and pituitary disorders.

The product is supplied as a single-use reagent kit and requires laboratory processing. It is classified under FDA regulation 862.1025 and was granted FDA 510(k) clearance (K926396) in 1993. No MRI safety or sterility claims are specified; storage and handling follow standard laboratory protocols for immunoassay kits. The product code CKG identifies it within the Clinical Chemistry category.

Other devices from Nichols Institute

See all devices from Nichols Institute →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Nichols ACTH radioimmunoassay kit used for?

    This kit is designed for the quantitative analysis of adrenocorticotropic hormone (ACTH) in clinical chemistry applications. By measuring ACTH levels in serum or plasma, it supports the diagnosis and monitoring of conditions such as adrenal insufficiency, Cushing’s syndrome, and pituitary disorders. The immunochemical technique ensures precise detection, helping clinicians assess hormonal imbalances.

  • How is the Nichols ACTH radioimmunoassay kit supplied and used?

    The kit is supplied as a single-use reagent kit, intended for laboratory processing only. It requires specialized equipment and trained personnel to perform the radioimmunoassay procedure. The instructions provided with the kit outline the steps for accurate measurement, including sample preparation, incubation, and detection phases, ensuring reliable results for clinical decision-making.

  • Is the Nichols ACTH radioimmunoassay kit sterile, and how should it be stored?

    The kit does not specify any claims regarding sterility, so standard laboratory protocols for immunoassay reagents should be followed. Storage should adhere to manufacturer guidelines, typically involving refrigeration (2–8°C) and protection from light and moisture. Always check the included documentation for precise storage instructions to maintain reagent integrity and accuracy.

  • Can the Nichols ACTH radioimmunoassay kit be reused, and what sizes or models are available?

    The kit is explicitly designed for single-use only, as indicated in the product description. While multiple FEI numbers are listed in regulatory records, these pertain to administrative categorization (e.g., product codes) rather than distinct sizes or models of the kit itself. The primary distinction lies in the product code CKG under the Clinical Chemistry category, ensuring compliance with FDA regulations.

  • What regulatory pathway does the Nichols ACTH radioimmunoassay kit follow?

    This kit was granted FDA 510(k) clearance (K926396) under the Traditional 510(k) pathway in 1993, classified as substantially equivalent to a predicate device. It falls under FDA regulation 862.1025 and is categorized under Clinical Chemistry (product code CKG). The clearance was reviewed by the Clinical Chemistry (CH) Advisory Committee, confirming its compliance with safety and effectiveness standards for diagnostic use.